keyword
MENU ▼
Read by QxMD icon Read
search

smfm

keyword
https://www.readbyqxmd.com/read/28198038/likelihood-of-cesarean-delivery-after-applying-leading-active-labor-diagnostic-guidelines
#1
Jeremy L Neal, Nancy K Lowe, Julia C Phillippi, Sharon L Ryan, Amy M Knupp, Mary S Dietrich, Stephen F Thung
BACKGROUND: Friedman, the United Kingdom's National Institute for Health and Care Excellence (NICE), and the American College of Obstetricians and Gynecologists/Society for Maternal-Fetal Medicine (ACOG/SMFM) support different active labor diagnostic guidelines. Our aims were to compare likelihoods for cesarean delivery among women admitted before vs in active labor by diagnostic guideline (within-guideline comparisons) and between women admitted in active labor per one or more of the guidelines (between-guideline comparisons)...
February 15, 2017: Birth
https://www.readbyqxmd.com/read/28142152/improving-safe-and-effective-use-of-drugs-in-pregnancy-and-lactation-workshop-summary
#2
Laura E Riley, Alison G Cahill, Richard Beigi, Renate Savich, George Saade
In February 2015, given high rates of use of medications by pregnant women and the relative lack of data on safety and efficacy of many drugs utilized in pregnancy, the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the Society for Maternal-Fetal Medicine (SMFM), the American College of Obstetricians and Gynecologists (ACOG), and the American Academy of Pediatrics (AAP) convened a group of experts to review the "current" state of the clinical care and science regarding medication use during the perinatal period...
January 31, 2017: American Journal of Perinatology
https://www.readbyqxmd.com/read/28135740/smfm-2017-meeting-highlights-saturday-podcast
#3
(no author information available yet)
No abstract text is available yet for this article.
January 30, 2017: American Journal of Perinatology
https://www.readbyqxmd.com/read/28131106/smfm-2017-meeting-highlights-friday-podcast
#4
(no author information available yet)
No abstract text is available yet for this article.
January 28, 2017: American Journal of Perinatology
https://www.readbyqxmd.com/read/28129660/smfm-2017-meeting-highlights-thursday-podcast
#5
(no author information available yet)
No abstract text is available yet for this article.
January 27, 2017: American Journal of Perinatology
https://www.readbyqxmd.com/read/28126367/smfm-statement-the-choice-of-progestogen-for-the-prevention-of-preterm-birth-in-women-with-singleton-pregnancy-and-prior-preterm-birth
#6
(no author information available yet)
No abstract text is available yet for this article.
January 23, 2017: American Journal of Obstetrics and Gynecology
https://www.readbyqxmd.com/read/28126365/prenatal-acetaminophen-use%C3%A2-and-outcomes%C3%A2-in%C3%A2-children
#7
(no author information available yet)
No abstract text is available yet for this article.
January 23, 2017: American Journal of Obstetrics and Gynecology
https://www.readbyqxmd.com/read/28108157/smfm-statement-the-role-of-cervical-pessary-placement-to-prevent-preterm-birth-in-clinical-practice
#8
(no author information available yet)
No abstract text is available yet for this article.
January 17, 2017: American Journal of Obstetrics and Gynecology
https://www.readbyqxmd.com/read/28108156/smfm-consult-series-42-the-role-of-ultrasound-in-women-who-undergo-cell-free-dna-screening
#9
Mary E Norton, Joseph R Biggio, Jeffrey A Kuller, Sean C Blackwell
The introduction of cell-free DNA (cfDNA) screening for aneuploidy into obstetric practice in 2011 revolutionized the strategies utilized for prenatal testing. The purpose of this document is to review the current data on the role of ultrasound in women who have undergone or are considering cfDNA screening. The following are SMFM recommendations: 1) in women who have already received a negative cfDNA screen, ultrasound at 11-14 weeks of gestation solely for the purpose of NT measurement (CPT code 76813) is not recommended (GRADE 1B); 2) we recommend that diagnostic testing should not be recommended to patients solely for the indication of an isolated soft marker in the setting of a negative cfDNA screen (GRADE 2B); 3) in women with an isolated soft marker without other clinical implications (ie, choroid plexus cyst or echogenic intracardiac focus) and a negative cfDNA screen, we recommend describing the finding as "not clinically significant" or as a "normal variant" (GRADE 2B); 4) in women with an isolated soft marker that has no other clinical implication (ie, choroid plexus cyst or echogenic intracardiac focus) and a negative first or second trimester screening result, we recommend describing the finding as "not clinically significant" or as a "normal variant" (GRADE 2B); 5) we recommend that all women in whom a structural abnormality is identified by ultrasound should be offered diagnostic testing with chromosomal microarray (GRADE 1A); 6) we recommend against routine screening for microdeletions with cfDNA (GRADE 1B)...
January 17, 2017: American Journal of Obstetrics and Gynecology
https://www.readbyqxmd.com/read/28061523/smfm-2017-pregnancy-meeting-looking-ahead-to-the-scientific-program-podcast
#10
(no author information available yet)
No abstract text is available yet for this article.
January 6, 2017: American Journal of Perinatology
https://www.readbyqxmd.com/read/27889286/computational-fluid-analysis-of-symptomatic-chronic-type-b-aortic-dissections-managed-with-the-streamliner-multilayer-flow-modulator
#11
Florian Stefanov, Sherif Sultan, Liam Morris, Ala Elhelali, Edel P Kavanagh, Violet Lundon, Mohamed Sultan, Niamh Hynes
OBJECTIVE: Managing symptomatic chronic type B aortic dissection (SCTBAD) by the Streamliner Multilayer Flow Modulator (SMFM) stent (Cardiatis, Isnes, Belgium) is akin to provisional structural support to induce complete attachment of the dissection flap, but with the ability of aortic remolding. This study investigated the SMFM's capability to enact healing of SCTBAD. METHODS: Clinical data for 12 cases comprising preoperative and postoperative treatment of SCTBAD were obtained from a multicenter database hosted by the Multilayer Flow Modulator Global Registry, Ireland...
November 23, 2016: Journal of Vascular Surgery
https://www.readbyqxmd.com/read/27819164/current-trends-in-the-diagnosis-and-management-of-gestational-diabetes-mellitus-in-the-united-states
#12
Brianne E Bimson, Barak M Rosenn, Sara A Morris, Elizabeth B Sasso, Rachelle A Schwartz, Lois E Brustman
OBJECTIVE: To assess current practice patterns among members of the Society for Maternal-Fetal Medicine (SMFM) with respect to the diagnosis and management of gestational diabetes mellitus (GDM). METHODS: A 38 question survey on GDM diagnosis and management was distributed to SMFM members. RESULTS: 2330 SMFM members were surveyed with a 40% response rate. Overall, 90.6% of respondents recommend a 2-step (versus a 1-step) diagnostic test. Cutoff values for the 1-h-50 g glucose challenge test vary from 130-140 mg/dL, but the majority (83%) adopts Carpenter Coustan criteria for the 3-h-100 g oral glucose tolerance test...
November 24, 2016: Journal of Maternal-fetal & Neonatal Medicine
https://www.readbyqxmd.com/read/27794277/smfm-2016-archive-hypertension-part-6-podcast
#13
(no author information available yet)
No abstract text is available yet for this article.
October 29, 2016: American Journal of Perinatology
https://www.readbyqxmd.com/read/27793058/smfm-2016-archive-hypertension-part-5-podcast
#14
(no author information available yet)
No abstract text is available yet for this article.
October 28, 2016: American Journal of Perinatology
https://www.readbyqxmd.com/read/27788535/smfm-2016-archive-hypertension-part-4-podcast
#15
(no author information available yet)
No abstract text is available yet for this article.
October 27, 2016: American Journal of Perinatology
https://www.readbyqxmd.com/read/27784119/smfm-2016-archive-hypertension-part-3-podcast
#16
(no author information available yet)
No abstract text is available yet for this article.
October 26, 2016: American Journal of Perinatology
https://www.readbyqxmd.com/read/27780276/smfm-2016-archive-hypertension-part-2-podcast
#17
(no author information available yet)
No abstract text is available yet for this article.
October 25, 2016: American Journal of Perinatology
https://www.readbyqxmd.com/read/27776365/smfm-2016-archive-hypertension-part-1-podcast
#18
(no author information available yet)
No abstract text is available yet for this article.
October 24, 2016: American Journal of Perinatology
https://www.readbyqxmd.com/read/27662643/prenatal-screening-for-microcephaly-an-update-after-three-decades
#19
Shari E Gelber, Amos Grünebaum, Frank A Chervenak
BACKGROUND: Due to the recent outbreak of Zika virus, there has been a newfound interest in fetal and neonatal microcephaly. In 1984, Chervenak et al. proposed criteria for the prenatal ultrasound diagnosis of microcephaly as ≤3 standard deviations (SD) from the mean. Despite improvements in medicine these criteria have not been reevaluated in 30 years. OBJECTIVE: To examine how the original 1984 Chervenak et al. criteria for the diagnosis of fetal microcephaly apply to a current population utilizing modern ultrasound equipment and techniques...
February 1, 2017: Journal of Perinatal Medicine
https://www.readbyqxmd.com/read/27638987/joint-sogc-ccmg-opinion-for-reproductive-genetic-carrier-screening-an-update-for-all-canadian-providers-of-maternity-and-reproductive-healthcare-in-the-era-of-direct-to-consumer-testing
#20
R Douglas Wilson, Isabelle De Bie, Christine M Armour, Richard N Brown, Carla Campagnolo, June C Carroll, Nan Okun, Tanya Nelson, Rhonda Zwingerman, Francois Audibert, Jo-Ann Brock, Richard N Brown, Carla Campagnolo, June C Carroll, Isabelle De Bie, Jo-Ann Johnson, Nan Okun, Melanie Pastruck, Karine Vallée-Pouliot, R Douglas Wilson, Rhonda Zwingerman, Christine Armour, David Chitayat, Isabelle De Bie, Sara Fernandez, Raymond Kim, Josee Lavoie, Norma Leonard, Tanya Nelson, Sherry Taylor, Margot Van Allen, Clara Van Karnebeek
OBJECTIVE: This guideline was written to update Canadian maternity care and reproductive healthcare providers on pre- and postconceptional reproductive carrier screening for women or couples who may be at risk of being carriers for autosomal recessive (AR), autosomal dominant (AD), or X-linked (XL) conditions, with risk of transmission to the fetus. Four previous SOGC- Canadian College of Medical Geneticists (CCMG) guidelines are updated and merged into the current document. INTENDED USERS: All maternity care (most responsible health provider [MRHP]) and paediatric providers; maternity nursing; nurse practitioner; provincial maternity care administrator; medical student; and postgraduate resident year 1-7...
August 2016: Journal of Obstetrics and Gynaecology Canada: JOGC, Journal D'obstétrique et Gynécologie du Canada: JOGC
keyword
keyword
64853
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"